{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:10:16Z","timestamp":1789560616828,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgeb.2026.100784","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:27:07Z","timestamp":1786364827000},"page":"100784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-34a and miR-223 as diagnostic biomarkers for the severity of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5139-4412","authenticated-orcid":false,"given":"Ammar Kadhim","family":"Alzubaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0991-0455","authenticated-orcid":false,"given":"Farah Abdulwahab","family":"Al-Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-3304","authenticated-orcid":false,"given":"Yasir B.","family":"Fadhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.jgeb.2026.100784_bb0005","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: definition and subtypes","volume":"29","author":"Han","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/medicines6010041","article-title":"The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease","volume":"6","author":"Iqbal","year":"2019","journal-title":"Medicines"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100784_bb0020","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms26062758","article-title":"Non-alcoholic fatty liver disease (NAFLD) management in the community","volume":"26","author":"Park","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.jgeb.2026.100784_bb0025","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.3748\/wjg.v27.i23.3238","article-title":"Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis","volume":"27","author":"Seen","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jgeb.2026.100784_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154259","article-title":"Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease","volume":"111","author":"Long","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jgeb.2026.100784_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/s0004-2803.202200001-19","article-title":"Should routine liver biopsy be considered in bariatric surgical practice? An analysis of the limitations of non-invasive NAFLD markers","volume":"59","author":"Concon","year":"2022","journal-title":"Arq Gastroenterol"},{"issue":"23","key":"10.1016\/j.jgeb.2026.100784_bb0040","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.3390\/nu14234969","article-title":"The diagnostic and prognostic value of the triglyceride-glucose index in metabolic dysfunction-associated fatty liver disease (MAFLD): a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jgeb.2026.100784_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.615978","article-title":"Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment","volume":"8","author":"Heyens","year":"2021","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100784_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020782","article-title":"The role of microRNA-22 in metabolism","volume":"26","author":"Tomasini","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100784_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158657","article-title":"Activation of the miR-34a\/SIRT1\/p53 signaling pathway contributes to the progress of liver fibrosis via inducing apoptosis in hepatocytes but not in HSCs","volume":"11","author":"Tian","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jgeb.2026.100784_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.527059","article-title":"miRNA dysregulation in the development of non-alcoholic fatty liver disease and the related disorders type 2 diabetes mellitus and cardiovascular disease","volume":"7","author":"L\u00f3pez-Pastor","year":"2020","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100784_bb0065","doi-asserted-by":"crossref","first-page":"C588","DOI":"10.1152\/ajpcell.00253.2022","article-title":"Circulating miRNAs associated with nonalcoholic fatty liver disease","volume":"324","author":"Atic","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113336","article-title":"MiR-34a-5p promotes hepatic gluconeogenesis by suppressing SIRT1 expression","volume":"420","author":"Wang","year":"2022","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jgeb.2026.100784_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860661","article-title":"MiR-223 as a regulator and therapeutic target in liver diseases","volume":"13","author":"Gu","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.jgeb.2026.100784_bb0080","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1172\/JCI122258","article-title":"Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223","volume":"129","author":"Calvente","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0085","doi-asserted-by":"crossref","first-page":"988","DOI":"10.15212\/bioi-2025-0060","article-title":"MicroRNAs in liver fibrosis: unraveling intercellular crosstalk and the regulatory functions of MicroRNA-223","volume":"6","author":"Phetkong","year":"2025","journal-title":"BIO Integr"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100784_bb0090","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jcm5030030","article-title":"Circulating microRNAs as potential biomarkers in non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Afonso","year":"2016","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100784_bb0095","doi-asserted-by":"crossref","first-page":"180","DOI":"10.14744\/hf.2025.17142","article-title":"Role of micrornas in the pathophysiology and diagnosis of metabolic dysfunction-associated steatotic liver disease: A bibliometric review","volume":"6","author":"Locatelli","year":"2025","journal-title":"Hepatol Forum"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100784_bb0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jhep.2024.03.035","article-title":"Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases","volume":"81","author":"Thiele","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s43586-023-00246-7","article-title":"Nanotechnology-based mRNA vaccines","volume":"3","author":"Chen","year":"2023","journal-title":"Nat Rev Methods Primers"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100784_bb0110","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/ijms26062392","article-title":"Expression analysis of circulating Mir-21, Mir-34a and Mir-122 and redox status markers in metabolic dysfunction-associated steatotic liver disease patients with and without type 2 diabetes","volume":"26","author":"Erceg","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100784_bb0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13105-025-01110-w","article-title":"The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD","volume":"81","author":"Tobaruela-Resola","year":"2025","journal-title":"J Physiol Biochem"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100784_bb0120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00432-024-05830-2","article-title":"LINC00525 enhances ZNF460-regulated CD24 expression through the sponge miR-125a-5p to promote malignant progression of breast cancer","volume":"150","author":"Wang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"10.1016\/j.jgeb.2026.100784_bb0125","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3390\/microorganisms12122475","article-title":"Effective inhibitor removal from wastewater samples increases sensitivity of RT-dPCR and sequencing analyses and enhances the stability of wastewater-based surveillance","volume":"12","author":"Linzner","year":"2024","journal-title":"microorg"},{"issue":"20","key":"10.1016\/j.jgeb.2026.100784_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gni178","article-title":"Real-time quantification of microRNAs by stem\u2013loop RT\u2013PCR","volume":"33","author":"Chen","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100784_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinme.2025.100304","article-title":"Implementation of SAMPL guidelines: recommendations for improving statistical reporting in biomedical journals","volume":"25","author":"Ordak","year":"2025","journal-title":"Clin Med"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/aogs.14760","article-title":"Updated guidelines for the reporting of methods and statistical analyses","volume":"103","author":"Sedgwick","year":"2023","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"10","key":"10.1016\/j.jgeb.2026.100784_bb0145","doi-asserted-by":"crossref","DOI":"10.5124\/jkma.25.0028","article-title":"Diagnostic and therapeutic relevance of non-coding RNAs in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a systematic review","volume":"68","author":"Naseer","year":"2025","journal-title":"J Korean Med Assoc"},{"issue":"7","key":"10.1016\/j.jgeb.2026.100784_bb0150","first-page":"516","article-title":"Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease\u2014results from the large AtheroGene study","volume":"38","author":"Karakas","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s43141-023-00467-z","article-title":"Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease","volume":"21","author":"Ragab","year":"2023","journal-title":"J Genet Eng Biotechnol"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100784_bb0160","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100784_bb0165","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141513","article-title":"Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223\u2013enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis","volume":"131","author":"He","year":"2021","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100784_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.apsb.2015.01.002","article-title":"Emerging role of microRNAs in lipid metabolism","volume":"5","author":"Yang","year":"2015","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100784_bb0175","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.30645","article-title":"MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes","volume":"70","author":"He","year":"2019","journal-title":"Hepatol"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100784_bb0180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HEP.0000000000001309","article-title":"Neutrophil serine proteases NE and PR3 controlled by the miR-223\/STAT3 axis potentiate MASH and liver fibrosis","volume":"83","author":"Zhang","year":"2026","journal-title":"Hepatol"},{"issue":"5","key":"10.1016\/j.jgeb.2026.100784_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13479","article-title":"Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s43162-025-00511-z","article-title":"Circulating microRNAs as potential non-invasive biomarkers for diagnosis and severity assessment of metabolic dysfunction-associated steatotic liver disease: a case\u2013control study","volume":"37","author":"Nafeh H","year":"2025","journal-title":"Egypt J Intern Med"},{"issue":"21","key":"10.1016\/j.jgeb.2026.100784_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111905","article-title":"Clinical and molecular biomarkers for diagnosis and staging of NAFLD","volume":"22","author":"Di Mauro","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12876-020-01334-8","article-title":"Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"20","author":"Xin","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jgeb.2026.100784_bb0205","first-page":"1837","article-title":"Serum Mir-34A and Mir-122 as an early non-invasive diagnostic marker for simple steatosis and NASH in comparison to FIB-4","volume":"3","author":"Abouelhassan","year":"2022","journal-title":"J Clin Images Med Case Rep"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100784_bb0210","doi-asserted-by":"crossref","DOI":"10.5501\/wjv.v14.i2.101976","article-title":"Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients","volume":"14","author":"Kaur","year":"2025","journal-title":"World J Virol"},{"issue":"8","key":"10.1016\/j.jgeb.2026.100784_bb0215","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jgeb.2026.100784_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300631","article-title":"Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL\/NASH: impact of LPS\/TLR-4\/FoxO3 pathway","volume":"357","author":"Samy","year":"2024","journal-title":"Arch Pharm"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100784_bb0225","article-title":"Elevated miR-34a induced by lipotoxicity and inflammation mediates pathophysiological communication between hepatocytes and hepatic stellate cells in liver fibrosis","volume":"12","author":"Duan","year":"2025","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1017\/S095442242100038X","article-title":"NAFLD and vitamin D: evidence for intersection of microRNA-regulated pathways","volume":"36","author":"Zhang","year":"2023","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.jgeb.2026.100784_bb0235","article-title":"Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100784_bb0240","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4254\/wjh.v13.i11.1584","article-title":"Heterogeneity of non-alcoholic fatty liver disease: implications for clinical practice and research activity","volume":"13","author":"Pal","year":"2021","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100784_bb0245","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21623945.2022.2098583","article-title":"Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p","volume":"1","author":"Niu","year":"2022","journal-title":"Adipocyte"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100784_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0153-7","article-title":"Role of miR-223 in the pathophysiology of liver diseases","volume":"50","author":"Ye","year":"2018","journal-title":"Exp Mol Med"}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26001289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:50:23Z","timestamp":1789559423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26001289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1687157X26001289"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100784","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-34a and miR-223 as diagnostic biomarkers for the severity of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100784"}}